Latest News
From the Journals
Risk Assessment Tool Can Help Predict Fractures in Cancer
Researchers collected data on bone mineral density and fractures in 9,877 patients with cancer and 45,875 matched control individuals without...
From the Journals
SBRT or Prostatectomy for Localized Prostate Cancer: Is One Better?
Researchers compared and evaluated quality-of-life outcomes among patients with prostate cancer who were assigned to undergo either SBRT or...
Latest News
ACOG Updates Breast Cancer Screening Guidelines
The updated breast cancer screening guidelines recommend that individuals at an average risk for breast cancer...
Latest News
How Doctors Use Music to Learn Faster and Perform Better
Listening to music and playing instruments improves doctors focus, energy, work performance, and well-being.
From the Journals
Is BMI Underestimating Breast Cancer Risk in Postmenopausal Women?
Researchers conducted a case-control study including 1,033 breast cancer cases and 1,143 postmenopausal population controls; both BMI and body fat...
Commentary
The New Cancer Stats Might Look Like a Death Sentence. They Aren’t.
Data show that people under 50 are experiencing higher rates of cancer than any generation before them.
Latest News
Fear of Cancer Recurrence Can Persist for Childhood Survivors
Overall, 16.6% of adult survivors of childhood cancer reported clinically significant fear that their cancer would recur, and an additional 15.7%...
Latest News
One-Dose HPV Vaccine Program Would Be Efficient in Canada
The model projected that a noninferior one-dose, gender-neutral HPV vaccination program would avert a similar number of cervical cancer cases,...
Feature
70% of Doctors Would Discharge Noncompliant Patients, Medscape Survey Finds
Doctors discussed discharging a patient, accepting gifts, romantic relationships with patients, and other topics.
News
FDA Approves Pfizer’s Hympavzi for Hemophilia A, B
New weekly injection treatment option to prevent or reduce bleeding in hemophilia A and B for patients aged 12 and older gets FDA approval.
Latest News
Time to Stop Saying Thyroid Cancer Is a ‘Good’ Cancer
Although papillary thyroid cancer outcomes generally are good, the disease can still be life-altering for years to come.